Inger Oulie

Author PubWeight™ 6.27^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Phase I trial of the positron-emitting Arg-Gly-Asp (RGD) peptide radioligand 18F-AH111585 in breast cancer patients.	J Nucl Med	2008	2.27
2	Disposition of perfluorobutane in rats after intravenous injection of Sonazoid.	Ultrasound Med Biol	2006	1.04
3	In vitro stability analyses as a model for metabolism of ferromagnetic particles (Clariscan), a contrast agent for magnetic resonance imaging.	J Pharm Biomed Anal	2002	0.90
4	Nc100668, a new tracer for imaging of venous thromboembolism: disposition and metabolism in rats.	Drug Metab Dispos	2005	0.79
5	Preparative high-performance liquid chromatographic separation and analysis of the Maltacine complex - a family of cyclic peptide antibiotics from Bacillus subtilis.	J Chromatogr B Analyt Technol Biomed Life Sci	2004	0.77
6	GE-145, a new low-osmolar dimeric radiographic contrast medium.	Acta Radiol	2010	0.76
7	Quantification of NC100668, a new tracer for imaging of venous thromboembolism, in human plasma using reversed-phase liquid chromatography coupled with electrospray ionization ion-trap mass spectrometry.	J Chromatogr B Analyt Technol Biomed Life Sci	2005	0.75
8	NC100668, a new tracer tested for imaging of venous thromboembolism: pharmacokinetics and metabolism in humans.	Drug Metab Dispos	2007	0.75